Can small laboratories afford automated sample preparation systems?

Automated sample preparation systems have long been associated with large, well-funded reference laboratories. The assumption is straightforward: high-end automation carries a high-end price tag, making it accessible only to institutions with substantial capital budgets. But that assumption deserves a closer look. As laboratory automation technology has matured and supplier models have evolved, the financial calculus has shifted considerably. Smaller laboratories analyzing environmental contaminants such as PFAS, dioxins, PCBs, and PBDEs now have more realistic pathways to automation than ever before.

The question is not simply whether a small laboratory can afford automated sample preparation systems. The more useful question is whether it can afford not to automate. Understanding the full cost picture, from upfront investment through long-term operational savings, is essential before drawing any conclusions about affordability.

The real cost breakdown of lab automation

The sticker price of a laboratory automation system is only one component of its true cost. To evaluate affordability accurately, laboratories need to account for the total cost of ownership, which includes installation, training, consumables, maintenance, and the less visible costs of not automating.

Manual sample preparation for contaminant analysis is labor-intensive and chemically demanding. Analysts working with persistent organic pollutants routinely spend hours on extraction, cleanup, and concentration steps that require significant quantities of organic solvents, including hazardous compounds like dichloromethane. The costs here accumulate quickly: solvent procurement, safe storage, waste disposal, personal protective equipment, and the staff time consumed by repetitive manual steps. When these are tallied honestly, the operational baseline for manual workflows is higher than many laboratory managers initially realize.

Automation shifts this cost structure. Systems designed for PFAS SPE automation or PBDE analysis automation consolidate multiple preparation steps into a single, programmable workflow. The upfront capital expenditure is real, but it displaces a recurring and often underestimated stream of operational costs. Viewing automation purely as a capital purchase, rather than as a replacement for ongoing expenditure, is one of the most common financial misjudgments smaller laboratories make.

How automation reduces operational costs over time

The operational savings from laboratory automation compound over time in several distinct ways. Labor efficiency is typically the most immediate and measurable benefit. When a system can run unattended through extraction and purification sequences, analysts are freed to perform higher-value tasks, effectively increasing laboratory capacity without increasing headcount.

Solvent consumption is another area where automated systems deliver consistent savings. Modern automated sample preparation platforms are specifically engineered to minimize solvent use. Systems using the Randall extraction principle, for example, can process up to six solid samples using less than 100 mL of solvent per sample. This reduction directly lowers solvent purchasing costs and, equally importantly, reduces the volume of hazardous waste requiring regulated disposal, which carries its own cost in many European jurisdictions.

Reproducibility represents a third financial benefit that is easy to overlook. Manual sample preparation introduces analyst-to-analyst variability, which can lead to failed quality control checks, repeated analyses, and the associated cost of re-running samples. Automated systems execute the same method with the same parameters every cycle, reducing rework rates and improving the reliability of results delivered to clients. Over a year of operation, the cumulative value of avoided reruns can be substantial for a laboratory operating under tight turnaround commitments.

Scalable systems designed for smaller lab budgets

One of the most significant developments in the laboratory automation market is the emergence of genuinely scalable platforms. Rather than requiring laboratories to purchase a single high-capacity system sized for maximum throughput, modern suppliers offer configurations that match the actual workload of smaller operations.

Solid phase extraction systems, for instance, are available in multi-channel configurations ranging from three to twelve channels, allowing a laboratory to start with a configuration suited to its current sample volume and expand as demand grows. Similarly, automated SPE platforms designed for PFAS analysis can process batches of varying sizes, with the ability to switch between sample racks for small or large volumes without significant downtime or reconfiguration effort.

For laboratories focused on solid and semi-solid matrices, extraction systems based on established solvent extraction principles offer a practical entry point into automation. A system capable of processing up to six samples in a single run, using standardized solvent volumes, provides meaningful throughput gains without demanding the infrastructure of a high-volume reference laboratory. The key for smaller laboratories is identifying which preparation steps consume the most analyst time and targeting automation there first, rather than attempting to automate an entire workflow simultaneously.

Financing and partnership models that lower the barrier

Capital constraints remain a genuine challenge for smaller laboratories, but the financing landscape around laboratory automation has become more flexible. Equipment leasing arrangements allow laboratories to access modern automated systems without a large upfront payment, spreading the cost over a defined term while benefiting from the operational savings the system generates from day one. In many cases, the monthly lease cost is partially or fully offset by reductions in solvent expenditure and labor hours within the first year of operation.

Supplier partnership models also play an important role. Distributors who specialize in automated sample preparation, rather than offering it as one product line among many, typically provide deeper pre-sale consultation, application-specific configuration, and post-installation support. This is particularly relevant for smaller laboratories that lack dedicated instrumentation specialists. A laboratory automation supplier that offers pre-installation programming, method validation support, and ongoing technical assistance effectively reduces the internal expertise required to operate sophisticated systems, lowering the hidden cost of adoption.

Some suppliers also offer analytical outsourcing arrangements that allow laboratories to access accredited analysis capacity during periods when their own throughput is insufficient to justify full automation. This hybrid model, where a laboratory builds its own automated capability incrementally while outsourcing peak demand, provides a lower-risk pathway to full in-house automation over time.

Regulatory compliance as a financial driver

Regulatory requirements for contaminant analysis are not static. Across Europe and North America, monitoring programs for PFAS, dioxins, PCBs, and PBDEs in food, feed, water, and environmental matrices have expanded steadily. Laboratories that serve regulated industries face increasing pressure to demonstrate method performance, maintain accreditation, and deliver results that meet evolving analytical criteria.

Manual sample preparation methods that were acceptable under earlier regulatory frameworks are increasingly scrutinized for reproducibility, traceability, and solvent use. Automated systems generate detailed run logs, maintain consistent extraction parameters, and produce results with documented reproducibility, all of which support accreditation audits and method validation submissions. For a laboratory pursuing or maintaining ISO 17025 accreditation, the ability to demonstrate automated, controlled sample preparation workflows has real regulatory value.

There is also a forward-looking dimension to this argument. Laboratories that invest in automation now are better positioned to take on new regulated analytes and expanded monitoring requirements as they emerge, without rebuilding their sample preparation infrastructure from scratch. The cost of compliance, viewed across a multi-year horizon, often favors early investment in automation over repeated incremental upgrades to manual workflows.

How DSP-Systems helps small laboratories access automation

DSP-Systems works directly with smaller laboratories across Europe and North America to make laboratory automation practical and financially realistic. Their offering addresses the core barriers that hold smaller operations back:

Scalable systems including the SPE2000, AutoEmpore, and GO-EHT platforms, configurable to match current sample volumes with room to grow
Minimal solvent use across all systems, reducing ongoing operational costs and hazardous waste disposal requirements
Elimination of cross-contamination risk, as samples do not come into direct contact with the system, supporting reliable results and accreditation compliance
Pre-installation programming and application testing configured to EPA and CEN standards, reducing the internal expertise required for deployment
Analytical outsourcing services through ISO 17025 accredited partner laboratories, providing a bridge for laboratories building toward full in-house automation
Method development and validation support across dioxins, PCBs, PFAS, PBDEs, pesticides, and other contaminant classes

If your laboratory is evaluating the move to automated sample preparation, contact DSP-Systems to discuss which configuration fits your current workload and long-term analytical goals.